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ABSTRACT 
 
Developing a Rate Equation Simulation Environment Using Microsoft Silverlight.  
(December 2009) 
Adam Laney Stevenson, B.S., Texas A&M University 
 Chair of Advisory Committee:  Dr. Bruce Riley 
 
 The exponential growth of information demands the automated movement of 
data and software via new software models that are able to integrate data and 
components on their own without scientists’ direct involvement.  However, current 
stand-alone software modeling environments do not support a secure software execution, 
nor do client server applications allow user customization of the software running on the 
servers.  To address this problem, a biological pathway modeling environment was built 
as a stand-alone Rich Internet Application (RIA).  The modeling environment was tested 
by constructing a simulation of the glycolysis pathways in the human erythrocytes, and 
the results were compared against one of the latest and richest erythrocyte metabolism 
models developed by Kuchel and Mulquiney.  The working simulation was able to settle 
into a quasi-stable state, with substrate concentrations close to what Kuchel and 
Mulquiney presented.   In later versions, it is hoped that the performance of the simulator 
can be increased and that it will become possible to link models together and add 
collaboration tools.   
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1. INTRODUCTION 
 A rich Internet application (RIA) simulation environment needs to be developed 
to give scientists the necessary software flexibility and integration capability required to 
handle the exponential information growth before them.  The magnitude and complexity 
of this information demand the availability and use of customizable automation tools 
that are capable of continuously turning this rising surge of information into a steady 
stream of predictive models and data summaries; anything less is outmoded. 
 In the recent past, data often just came in the form of papers, online databases, 
and distributed flat files.  But recently, metabases and wikis have been added to the list 
and are being increasingly used to gather and distribute user-generated content.  
Examples include Molecular Biology Database Collection and EcoliWiki.  These 
systems allow data inputters to be less constrained by data format and to share and 
collaborate in real time.  It is not uncommon to find relevant information about an 
experiment or methods to debug a simulation, to get help with training or a software 
tool, to talk to sales staff, or to view blogs, social networking sites, forums, and even 
virtual worlds [1].    
 A good example of how growing information complexity is affecting scientists 
can be found by studying the evolution of software used to perform biological pathway 
simulations.  When biological pathway simulations were first being built in the 1970s,  
 
 
___________ 
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speed and efficient use of memory were the primary constraints of the algorithms.  
Because the resources of the computers were so limited, often computer software models 
were limited to a few thousand lines of code.  However, it was also possible for 
scientists to build their own simulation software, obviating the need to rely on existing 
technology.  This ability allowed them to test new ideas without being constrained by 
design choices of others.   Thus, issues related to software diversification in the past 
were easier to overcome due to the small size of the models.  When desired, 
incorporating a feature of another program could be accomplished easily in a few hours 
because the amount of source code that needed to be added to the program was small.  
As technology improved, so also did the predictive power of the models and the 
complexity of the data analysis routines.  These technological changes resulted in much 
larger software code bases and, thus, it became cost prohibitive to develop modeling 
environments from scratch each time a new modeling experiment needed to be 
performed.  The result was that engineers bifurcated the modeling of software packages, 
separating the actual data models from the simulation routines so that investments in 
time and capital could become more reusable.   Over time, often as a result of the need to 
maximize performance or to guard market share if the software was commercialized, 
these modeling programs grew and became increasingly specialized.  As of 2006, there 
were twelve simulation environments that allowed scientists to simulate biological 
pathways with overlapping feature sets [2].  The downside to this increasing complexity 
is that building a competitive model often first requires the purchase, installation, and 
configuration of complex software packages like Mathematica, Matlab, or Maple to run 
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the packages [3]; alternatively, if scientists have enough time available, a modeling 
program can be developed from scratch, but even this possibility is discouraged [3].  
Also, due to complexity, size of the libraries involved, and the fact that many of these 
programs are closed source, making large modifications to the algorithms involved in the 
simulation can be unwieldy or perhaps impossible, given typical time constraints.  The 
result is that the diversification of the technologies has become a barrier to creating more 
complex, integrative models.   
It is not uncommon to find models of the same pathway using different 
technologies to perform the simulation, which often results in different input and output 
formats.  While there have been efforts to standardize the formats used, many programs 
either do not support the full standard or have bug-riddled implementations.  
Additionally, if a new feature is added to the program, the cost of implementing the 
feature in a standard fashion can cause the need for either the feature or the support for 
data standardization to be dropped.   
 An example of how increasing complexity simulates divergence can be observed 
by studying the evolution of the simulations dedicated to modeling the metabolism in 
erythrocytes.  The  model has been steadily evolving for over thirty-five years [3, 4, p. 
64], with the first mathematical model of erythrocyte glycolysis being published in 1974 
[5].  Since then, as the model has been tested and discrepancies found between the 
proposed model and the actual pathways, more parameters have been added.  The 
models have expanded until erythrocyte glycolysis has become one of the most well-
described and complex kinetic models published thus far.  To date, it has been the topic 
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of at least five major papers [6-10], and two books [3, 11]. Notably, almost all of these 
simulations use a different set of software tools.     
 This problem of increased complexity will worsen as biologists build models that 
integrate multiple biological levels which are observable in different time scales [4, p. 
671, 12, p. 9].  The increased complexities suggest the need to develop meta-models, a 
set of interconnected models of different biological pathways that can be used to more 
accurately mimic real biological systems.   
 To enable the creation of these larger models and meta-models, developers need 
the ability to share and interconnect models to form a self-updating information web.  
This self-updating web will prevent the increased quantity of available data from 
swamping modelers and also will allow the modeling environment to automatically re-
run the simulations when values change.  Such a system will enable the continuous 
integration and testing of models, which will greatly aide in the production of larger 
meta-models.   
   Enabling modeling systems to support the sharing and linking of parameters also 
will avoid the problem of data sources going offline.  As of 2009, the two major 
repositories of kinetic modeling constants are the Enzymes and Metabolic Pathways 
Database (EMP) [13] and the BRENDA database [14].  Unfortunately, the EMP 
database, one of the oldest and richest sources of kinetic modeling data, went offline this 
past spring, leaving the BRENDA database as the only major source available today.  
That database is in financial jeopardy as well.  This problem of losing data sources can 
be avoided by enabling the individual models and modeling environments to act as data 
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sources, instead of relying upon specific databases for information.  Facebook is a good 
example of an application that is adopting this strategy, as it provides both an application 
environment to manage social connections and resources for other applications to share 
and distribute data.   Establishing the same data redundancy grid between various kinetic 
simulators and other biological applications will help eliminate the problems associated 
with databases going offline and databases containing different sets of information [12].  
Additionally, building large meta-models will require the ability to link together 
independent models.  This will enable them to coordinate the sharing and updating of 
both model data and executable components, down to the individual compiled types, 
which contain the functions that execute the simulation.  Due to security and 
performance concerns, current server-based collaboration suites cannot offer this level of 
customization.  Desktop applications could do so if the application could run within a 
secure environment, as nobody wants a computer virus from an auto-updating model.  
Therefore, there is a need for modeling environments that can be coded as Rich Internet 
Applications (RIAs) and that can offer the customization of a desktop application, the 
collaborative features offered by server applications, and the necessary security to keep 
the application safe.  RIAs can also allow the resulting application to be cross-platform.  
Three new competing technologies can be used to develop RIAs, of which Silverlight 
provides the best mathematical performance and allows programmers to use a multitude 
of different languages to target a single runtime, thus making algorithm comparisons 
simpler to perform. 
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 Nevertheless, there are some downsides to using Silverlight.  The platform is 
only in its third conception with the fourth about to be in beta.  Thus, much functionality 
will need to be developed to allow for kinetic pathway modelers to build deterministic, 
ordinary differential equation (ODE)-based models.  Furthermore, to enable the linking 
of models and the collaboration of modelers in peer-to-peer fashion, it will be necessary 
to develop a small backend system to facilitate information synchronization between two 
Silverlight applications.  Solutions to these problems are in reach and several prototypes 
of these technologies have already been developed by the author.   
 Thus, a four-month study was performed to determine how to build a highly 
modular internet client application capable of simulating the human erythrocyte 
glycolysis pathway.    The initial capabilities of the simulation modeling environment 
were tested by building a model of the human erythrocyte glycolysis pathway and 
comparing the results to previous models of the same system.  This process will allow 
scientists to observe the potential for scaling the resulting prototype into a full-blown 
modeling environment.  Once the stand-alone version of the simulator is built, it will be 
possible then to propose the development of the multi-user version of the simulation 
environment and to add all the remaining collaboration features previously described.  
Furthermore, it is hoped that the development and testing of this prototypical simulation 
engine will encourage future extension of the model’s attributes and, thus, enable the 
depiction of all the erythrocytes’ pathways.  The culmination will be one integrated 
model that can be shared and not constrained by the tools used or the websites accessed 
during its development.  It is also hoped that this new model integration approach will 
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pave the way for scientists to build much more complicated models than can be built by 
current mathematical modeling programs. 
 The following summarize the major objectives of this project: 
  Build a stand-alone pathway simulator that can be run from the web using 
C#, the .NET Framework, and Microsoft Silverlight; 
  Test the framework by constructing a model of glycolysis pathways in the 
human erythrocytes and simulating it in the modeling environment; 
  Analyze the data from the human glycolytic erythrocyte model by 
comparing it to known experimental data and the data produced by other human 
erythrocyte metabolism models. 
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2. BACKGROUND 
 This section presents an overview of glycolysis and then details what is generally 
known about the enzymes present in the model. 
 
2. 1  GLYCOLYSIS 
 Glycolysis is a cellular process that extracts the energy from chemical bonds in 
glucose, a 6-carbon sugar, and transfers it temporarily to ATP (adenosine triphosphate) 
for later use by energy-requiring processes throughout the cell.  This biochemical 
pathway exists in all cells on earth, and because of this, it is considered one of the oldest 
energy-producing systems in existence.   
When glucose is readily available and ATP is in need, glucose enters the 
pathway from extracellular fluid at a rate of 2 μmol per ml per hour [11].  Once it enters, 
it undergoes ten biochemical reactions.  The pathway initially requires the expenditure of 
two ATP molecules per glucose to prime the pathway for subsequent glucose oxidation.  
Each cycle of the pathway yields four ATP molecules, two NADH molecules (another 
energy-carrying molecule), two pyruvates, and inorganic phosphate.  In most other cells 
that have mitochondria, pyruvate and NADH are fully oxidized to yield an additional 34 
ATP; however, as erythrocytes lack mitochondria, the pyruvate is converted instead to 
lactate via the enzyme lactate dehydrogenase and is exported from the cell as a waste 
product.   
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 Lactate production also converts NADH back to NAD+, thereby facilitating the 
next cycle of glycolysis.  Therefore, in erythrocytes, the net yield of the pathway is the 
production of two ATP molecules per glucose [11]. 
 The overall rate of the pathway is primarily controlled by the enzymes 
hexokinase (HK), phosphofructokinase (PFK), and pyruvate kinase (PK), with PFK 
having the most influence.  Pyruvate kinase acts at the end of the pathway and does not 
have much regulatory control.  Furthermore, while the reaction with glucose and HK is 
the first one, it is not always a required step if the sugar source is fructose (fruit sugar) 
instead of glucose.  Thus, this process leaves PFK as the only major flux-control point in 
the pathway.  PFK is always necessary for the production of pyruvate and acts near the 
beginning of the pathway, where feedback regulation can optimally control overall 
energy flow.  PFK activity is stimulated by high levels of AMP and ADP, which are 
prevalent in energy-depleted cells, and it is inhibited by the high levels of ATP to 
prevent over-utilization of glucose reserves [3, 15, 16].   
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Figure 1   Glycolysis and the removal of pyruvate via fermentation [3, p. 176]. 
 
 
  
 A diagram of the pathway with all substrates (reactants) and enzymes (proteins  
 
that accelerate each reaction) is shown in Figure 1. 
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2.2  SPECIFIC GLYCOLYSIS REACTIONS 
  
 The following summarizes all of the individual reactions that were modeled 
during the course of the study.  All equations were based on Mulquiney and Kuchel’s 
2003 book.  All table rate constants are from their 1999 paper.  
 
Phosphorylation of Glucose via Hexokinase 
  The reaction of MgATP and glucose with hexokinase (HK) is the first reaction in 
glycolysis.  Hexokinase requires a sugar and an ATP-Mg+2   to initiate the reaction [15, p. 
431].  The sugar is usually D-glucose, but the process will also operate on D-fructose 
and D-mannose  [16].  The ΔG'0  hexokinase is -16 kJ/mol, and it has a  keq  of 2000 [16].  
The high ΔG'0  of the reaction is not due to the cleavage of the sugar, but to the 
hydrolysis of ATP into ADP3-, Pi2 and H+.   
 The activity of HK is regulated by the competitive inhibitors Glucose-6-
Phosphate, 2,3-Bisphosphaogluycerate, Glucose-1,6-Bisphosphate, glutathione (GSH), 
and ATP [3, 15, p. 431].  When ATP is not bound to Mg+2, it acts as a strong 
competitive inhibitor, as the negative charges of phosphate oxygen atoms are not 
shielded by the Mg+2 ion, given the concentrations are greater than 4mM [17, p. 1].  
Therefore, the process results in the γ-phosphorus atom being less accessible for 
nucleophilic attack by C6-OH group of the sugar [15, p. 431]. 
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Table 1   Michaelis-Menten constants for hexokinase 
 
  
Reactant Name Km Ki kCat
MgAtp 1.00E‐03 n/a 180
Glucose n/a 4.70E‐05 n/a
Product Name Km Ki kCat
MgAdp 1.00E‐03 n/a 1.16
Glucose‐6‐Phosphate n/a 4.70E‐05 n/a  
   
 
 
Table 2  Inhibitors for hexokinase 
 
Inhibitor Type  Binding Site Ki
Glucose‐6‐Phosphate Competitive MgATP 1.00E‐05
2,3‐Bisphosphoglycerate Competitive MgATP 4.00E‐03
Glucose‐1,6‐Bisphosphate Competitive MgATP 3.00E‐05
Glutathione (GSH)   Competitive MgATP 3.00E‐03
ATP Competative MgATP 1.00E‐04  
 
 
 
 A rate equation for the enzymatic reaction can be formed by modeling the 
enzyme after the b-bi-random model [18] and incorporating the following constraints.  
The rate constants for the equation are listed in Table 1 and Table 2. 
 The hydrogen ion concentration affects the rate at which hexokinase produces 
products.  This dependency can be accounted for in the model by multiplying the KCat 
values by the bell equation, which is listed as Equation 2.1. 
          
            
 2
1
10 101
10 10
pH pH pk
pk pH
kk  
 

 
 (2.1) 
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Multiplying the forward and reverse rate constants by the bell equation results in  
Equations 2.2 and 2.3. 
         
 
9.55
7.02
180 1.662
10 101
10 10
f pH
pH
kcat  
 
           
 (2.2)               
 
9.55
7.02
1.16 1.662
10 101
10 10
r pH
pH
kcat  
 
           
 (2.3) 
  
 Equation 2.3 describes the inhibitor effects of the rate equation. 
            
 
, , 6 , , 6
6
i Glc i Glc P i Glc i Glc P
Glc Glc P Glc ATPI
K K K K
      (2.4) 
 Inserting Equation 2.3 into 2.4 forms the rate equation denominator. 
 
      , , , , ,
, 16 2 , , 16 2
1
16 2 16 2
i MgAtp i Glc m MgAtp i Glc i MgAdp
i Glc P m MgAdp i Glc P
MgAtp Glc MgAtp Glc MgAdpd
K K K K K
Glc P MgAdp Glc P I
K K K
     
 
      (2.5)
 Then, inserting 2.1, 2.2, and 2.3 into 2.5 forms the complete rate equation, 2.6.   
0
, , , , 16 2
16 2f r
i
m MgAtp i Glc m MgAdp i Glc P
kcat MgAtp GlcE kcat MgAdp Glc Pv vol
d K K K K
        
                                               (2.6) 
  
 Note, that because glucose is being imported from the outside of the cell, an 
internal  volume term has to be added to the equation (Mulquiney and Kuchel 2003, p. 
180).  
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If solving for the equation by the mechanism alone, the reaction conforms to the 
random bi-bi mechanism.  This mechanism is outlined below in Figure 2.  The rate 
constants for the reaction follow in Table 3. 
 
 
Figure 2  Random bi-bi mechanism with inhibition.  This mechanism can be used to 
construct a rate equation for hexokinase in a mechanistic fashion.  The inhibitor 
shown is actually four inhibitors, with each having its own k constant. 
 
 
Table 3  Constants used to simulate HK mechanism  
 
Value Units Constant Value Units
k1 k1 0.3 M‐1*s‐1 k‐1 k2 3 s‐1
k2 k3 6.4 M‐1*s‐1 k‐2 k4 3 s‐1
k3 k5 6.4 M‐1*s‐1 k‐3 k6 3 s‐1
k4 k7 0.3 M‐1*s‐1 k‐4 k8 3 s‐1
k5 k9 1.80E‐02 s‐1 k‐5 k10 1.36E‐04 s‐1
k6 k11 3 s‐1 k‐6 k12 0.3 M‐1*s‐1
k7 k13 3 s‐1 k‐7 k14 6.4 M‐1*s‐1
k8 k15 3 s‐1 k‐8 k16 6.4 M‐1*s‐1
k9 k17 3 s‐1 k‐9 k18 0.3 M‐1*s‐1
k10 k19 7.1 M‐1*s‐1 k‐10 k20 1 s‐1
k11 k21 0.075 M‐1*s‐1 k‐11 k22 3 s‐1
k12 k23 4.5 M‐1*s‐1 k‐12 k24 1 s‐1
k13 k25 0.1 M‐1*s‐1 k‐13 k26 3 s‐1
Constant
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Glucose Phosphate Isomerase (GPI) 
 
 The conversion of glucose-6-phosphate to fructose 6-phosphate via the use of 
glucose phosphate isomerase is the second preparatory step in glycolysis.  During this 
step, the covalent bond between the first carbon atom and the oxygen is broken and then 
reformed, but with the second carbon atom receiving the electrons instead of the first.  
This action initiates the process of making the carbon chain symmetrical before 
cleavage, so that both halves of the chain can proceed to become a pyruvate molecule 
downstream.  Unlike the previous step that is exergonic, this reaction is endergonic with 
a ΔG'o of 2.2; however, this positive free energy change is easily overcome from the 
favorability of other reactions in the pathway, as this reaction's keq of 0.4, is very near 
equilibrium  [16, p. 573].  
 This process is modeled using the standard reversible Michaelis-Menten model.  
Table 4 contains the constants for the standard model that can be inserted into Equations 
1.7 and 1.8.   
 
Table 4  Km and KCat constants used to build a model of GPI 
 
Reactant Name Km Ki kCat
Glucose‐6‐Phosphate 1.81E‐04 n/a 1470
Product Name Km Ki kCat
Fructose‐6‐Phosphate 7.10E‐05 n/a 1760  
  
 
, 6 , 6
6 61
m Glc P m Fru P
Glc P Fru Pd
K K
    (2.7) 
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 , ,0
, 6 , 6
6 6cat f cat r
m Glc P m Fru P
k Glc P k Fru PEv
d K K
       
 (2.8) 
 
Phosphofructokinase (PFK-1) 
 The phosphorylation of fructose 6-phosphate to fructose 1,6-bisphosphate is the 
second priming reaction in the glycolysis pathway.  In step one, a phosphate group was 
added to the sixth carbon; this reaction completes the symmetry by transferring a second 
phosphate group to the first fructose carbon from another MgATP complex.  Under 
normal cellular conditions, products are strongly favored due to the enzyme having a keq 
equal to 1200 [3] with a ΔG'o of -14.2 kJ/mol [16].  Table 5 lists the Km and kCat 
constants associated with PFK. 
 
 
Table 5  Reactants and products of PFK  
 
Reactant Name Km kCat
MgAtp 6.80E‐05 822
Fructose 6‐phosphate 7.50E‐05 n/a
Product Name Km kCat
MgAdp 5.40E‐04 36
Fructose 1,6‐bisphosphate 5.00E‐04 n/a  
 
 
 
 Phosphofructokinase is one of the primary regulatory enzymes in the pathway 
and can be strongly inhibited by high ATP, free Magnesium, and 2,3-
bisphosphoglycerate. When ATP concentrations are above 1E-4M, ATP inhibits the 
formation of fructose 1-6-bisphosphate by binding strongly to an allosteric site.  This 
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regulation helps prevent the pathway from burning excess amounts of glucose that could 
instead be stored for later catabolism using glycogenesis.  The other negative feedback 
mechanism is the production of 2,3-bisphosphoglycerate from 1,3-bisphosphoglycerate, 
through the 2,3-bisphosphoglycerate shunt.  This indirectly slows the production of ATP 
since 1,3-bishosphoglycerate is down stream of PFK.  A table of the inhibitors has been 
provided below in Table 6.   
 
Table 6  Associated Ki values of inhibitors regulating phosphofructokinase activity 
Inhibitor KT
Atp 1.00E‐04
Mg 4.00E‐03
B23PG 5.00E‐03  
 
 
 The enzyme is also activated by high levels of AMP which increase as ATP is 
consumed.  Phosphate and glucose-1,6-Bisphosphate are also known activators [3].  A 
list of PFK activators and their associated constants are listed in Table 7.    
 
Table 7  Associated Ki values of activators regulating PFK 
Activators KR
Amp 3.00E‐04
Phosphate 3.00E‐02
Glucose‐1,6‐Bisphosphate 1.00E‐02  
 
 
 PFK is an allosteric enzyme that can be modeled with two-state symmetry [19].  
This is done by adding an extra equation, 1.9, to the Michaelis-Menten model.   Unlike 
 18
most enzymes, allosteric enzymes take on different shapes based upon which substrates 
are currently bound.  This chameleon-like nature is due to the fact that they are often 
composed of multiple identical subunits, rather than just one subunit.  When bound to 
one subunit, a substrate can encourage or discourage other substrates from binding to the 
other identical units.   
 Examining Equation 1.9, the top terms are used to express the inhibitors and 
effects of pH on the enzyme, while the bottom terms represent both the substrates to be 
converted and the activators.   
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With the allosteric properties defined, the equation can be applied to the existing 
1.10 and 1.11 rate equations as if it were an additional inhibitor.  Without the application 
of 1.9, the rate equation is modeled as a normal random bi-bi rate equation.  
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Aldolase 
 The cleavage of fructose 1,6-bisphosphate into glyceraldehyde 3-phosphate and 
dihydroxyacetone phosphate is the fourth preparatory step of glycolysis.  During this 
system, the sugar is cleaved in half, and an aldose, glyceraldehyde 3-phosphate, and a 
ketose, dihydroxyacetone phosphate, are formed.  The aldose continues, while the ketose 
is converted to the aldose form in the next step of glycolysis.  Using the constants in 
Table 8, the mechanism in Figure 3 can be entered into any system supporting the King-
Altman algorithm.   
 
Table 8  Quasi first order constants used to solve for the Aldolase rate equation.  
All of the constants correspond to rate constants for the mechanism depicted in 
Figure 3.  
Value Units
k1 k1 1.18E+07 M‐1*s‐1
k‐1 k2 234 s‐1
k2 k3 995 s‐1
k‐2 k4 6.50E+06 M‐1*s‐1
k3 k5 73 s‐1
k‐3 k6 6.62E+06 M‐1*s‐1
k4 k7 1.00E+09 M‐1*s‐1
k‐4 k8 1.50E+06 s‐1
Constant
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Figure 3  Example of an ordered uni-bi mechanism with inhibition. All of the rate 
constants correspond to values in Table 8.   
 
 The resulting rate equation is an ordered uni-bi rate equation.  Equation 2.12 
depicts the denominator of the equation.  Equation 2.13 depicts the solved rate, with the 
associated constants referenced in Table 9.   
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Table 9  Solved Km, Kcat and Ki values for use in Eq. 2.12 and 2.13 
Reactant Name Km kCat Ki
Fructose 1,6‐bisphosphate 7.10E‐06 68 1.98E‐05
Product Name Km kCat Ki
Glyceraldehyde‐3‐Phosphate 1.89E‐04 234 n/a
Dihydroxyacetone Phosphate 5.00E‐04 n/a 1.10E‐05  
 
 
Triosphosphate  Isomerase 
 Only glyceraldehyde-3-phosphate (GAP) can proceed through the pathway, and 
dihydroxyacetone phosphate must be converted to glyceraldehyde-3-phosphate.  This  
conversion is performed by the enzyme trisphosphate isomerase, which converts the 
ketose to an aldose by breaking the double bond on the second carbon [15].  The reaction 
can be modeled by using the standard uni-uni reversible equation [18].  When this 
mechanism is solved, it results in Equations 2.14 and 2.15, with their respective 
constants listed in Table 10. 
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Table 10  Solved Km and Kcat values for use in Eq. 2.14 and 2.15  
Reactant Name Km kCat Ki
Dihydroxyacetone Phosphate 446E=6 1280 n/a
Product Name Km kCat Ki
Glyceraldehyde‐3‐Phosphate 1.62E‐04 14560 n/a  
 
 
Glyceraldehyde Phosphate Dehydrogenase 
 Glyceraldehyde phosphate dehydrogenase (GAPDH) oxidizes and 
phosphorylates glyceraldehyde-3-phosphate by NAD and Pi.  This is the last preparatory 
step before the reaction starts producing ATP molecules [15].  The reaction can be 
modeled by modeling the mechanism and solving for the rate equation  [18].  When this 
mechanism is solved, it results in Equations 2.16 and 2.17, with their respective 
mechanism constants listed in Table 11.    
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Table 11  Quasi first order constants used to solve for the GAPDH rate equation.  
All of the constants correspond to rate constants for the mechanism depicted in 
Figure 5. 
 
Simulation k Reference k Value Units
k1 k1 5.16E+06 M‐1s‐1
k‐1 k2 232 s‐1
k2 k3 1.00E+09 M‐1s‐1
k‐2 k4 3.48E+06 s‐1
k3 k5 255 s‐1
k‐3 k6 2.55E+08 M‐1s‐1
k4 k7 3.06E+06 M‐1s‐1
k‐4 k8 6.50E+02 s‐1
k5 k9 2.55E+03 s‐1
k‐5 k10 2.55E+08 M‐1s‐1
k6 k11 1.00E+09 M‐1s‐1
k‐6 k12 3.10E+04 s‐1  
 
 
 
 Table 12 shows the Michaelis-Menten constants that are solved for by 
rearranging the equation for the King-Altman algorithm.  Figure 4 outlines the 
mechanism. 
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Table 12  Solved Km, Kcat, and Ki values for use in Eq. 2.16 and 2.17 
 
Reactant Name Km kCat Ki Kid
Glyceraldehyde‐3‐Phosphate 9.50E‐05 232 1.59E‐19 3.10E‐05
NAD 4.50E‐05 n/a 4.50E‐05 n/a
Phosphate 3.16E‐03 n/a  3.16E‐03 n/a
Product Name Km kCat Ki Kid
1,3‐Bisphosphhoglycerate  6.71E‐07 171 1.52E‐21 1.00E‐06  
  
  
 
Figure 4  Diagram of GAPDH mechanism and the associated constants.  The values 
for these constants can be found in Table 11.  
 
  
Phosphoglycerate Kinase 
 Phosphoglycerate Kinase (PGK) transfers the phosphoryl group associated with 
the first carbon in 1,3-Bisphosphhoglycerate to ADP.  This results in the formation of 3-
phoshoglycerate and two ATP molecules per glucose molecule, which marks the first 
payoff step in the pathway [15].  The reaction can be modeled using a bi-bi rate equation 
[3, 18].  Solving this mechanism results in Equations 2.18 and 2.19, with their respective 
Michaelis-Menten  constants listed in Table 13.   
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Table 13  Solved Km and Kcat values for use in Eq. 2.18 and 2.19 
 
Reactant Name Km kCat Ki
MgAdp 1.00E‐04 2290 8.00E‐05
1,3‐Bisphosphhoglycerate  2.00E‐06 n/a 1.60E‐06
Product Name Km kCat Ki
MgAtp 1.00E‐03 917 1.86E‐04
Glyceraldehyde‐3‐Phosphate 1.10E‐03 n/a 2.05E‐04  
  
 
Phosphoglycerate Mutase   
 Phosphoglycerate mutase shifts the phosphoryl group associated with the number 
three carbon in 3-phosphoglcerate to the number two carbon, forming 2-
phosphoglycerate.  This is a primary preparatory step, and the reaction is practically 
energetically neutral [15]. The reaction can be modeled by using the standard uni-uni 
reversible equation [18].  When this mechanism is solved, it results in Equations 2.20 
and 2.21 with their respective constants listed in Table 14. 
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Table 14  Solved Km and Kcat values for use in Eq. 2.20 and 2.21  
Reactant Name Km kCat Ki
Dihydroxyacetone Phosphate 446E=6 1280 n/a
Product Name Km kCat Ki
Glyceraldehyde‐3‐Phosphate 1.62E‐04 14560 n/a  
  
 
 
Enolase 
 Enolase (ENO) dehydrates 2-phosphoglycerate to form phosphoenolpyruvate. 
This forms a double bond between the second and third carbons in phosphoenolpyruvate.  
[15].  The reaction can be modeled using a bi-bi rate equation [3, 18].  When this 
mechanism is solved, it results in Equations 2.22 and 2.23, with their respective 
Michaelis-Menten constants listed in Table 15.   
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Table 15  Solved Km and Kcat values for use in Eq. 2.22 and 2.23 
Reactant Name Km kCat Ki
Glyceraldehyde‐2‐Phosphate 1.40E‐04 190 1.40E‐04
Mg 4.60E‐05 n/a 4.60E‐05
Product Name Km kCat Ki
Phosphoenolpyruvate 1.11E‐04 50 1.11E‐04  
  
 
Pyruvate Kinase 
 The last step in the glycolysis pathway is the conversion of phosphoenolpyruvate 
to pyruvate via pyruvate kinase.  This step produces another two ATP molecules per 
glucose molecule that enters the system, which raises the total ATP produced to four and 
the net to two.  During this reaction, the phosphoryl group is transferred from 
phosphoenolpyruvate to ADP; the double bond also is shifted from being between the 
third carbon to being between the second and the associated oxygen, once the 
phosphoryl group leaves the oxygen.   Like PFK, this enzyme is allosteric in nature and 
can be modeled by multiplying the denominator by the term (1+L), with L defined in 
Equation 2.22.  The rest follows a bi-bi-reaction mechanism, and can be described with 
Equations 2.23 and 2.24.  The associated Michaelis-Menten constants are listed in Table 
16.  
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Table 16  Solved Km and Kcat values for use in Eq. 2.22, 2.23, and 2.24  
Reactant Name KR kCat KT
MgAdp 4.74E‐04 1386 n/a
Phosphoenolpyruvate 2.25E‐04 n/a n/a
Atp n/a n/a 3.39E‐03
Product Name KR kCat Ki
MgAtp 3.00E‐03 3.26 n/a
Pyruvate 2.00E‐03 n/a n/a  
 
 
 
Lactate Dehydrogenase (LDH) 
 The removal of pyruvate via the conversion to lactate is not technically in the 
glycolysis pathway by definition, but without it, the NAD concentration cannot be 
regenerated and the pyruvate in the system cannot be adequately removed.  Thus, it is 
required to have lactate dehydrogenase in the system.   LDH can be modeled by random-
ordered-ternary-complex mechanism, given rapid-equilibrium is assumed [20].  When 
this mechanism is solved, Equations 2.25 and 2.26 are generated.  Their respective 
constants are listed in Table 17.  
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Table 17  Solved Km, Ki, Kcat, and Kid values for use in Eq. 2.22, 2.23, and 2.24 
Reactant Name Km kCat Ki Kid
Pyruvate 1.37E‐04 458 2.28E‐04 1.01E‐04
NADH 8.44E‐06 n/a 2.45E‐06 n/a
Product Name Km kCat Ki Kid
Lactate 1.07E‐03 115 7.33E‐03 n/a
NAD 1.07E‐04 n/a ‐3.00E+00 n/a  
 
 
 
Other Minor Supporting Reactions 
 There are a few other reactions that have to be included in the model. These 
include the production of MgATP, MgADP, Amp, the consumption of NADH, and the 
membrane transport reactions.  Their full definitions can be found in Kuchel's book [3, p. 
283 - 290].   Because these reactions do not follow the standard Michaelis-Menten 
pattern, these reactions are modeled by creating equation classes, instigating them and 
loading them into simulation.  
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2.3  HISTORY 
 
The first paper presenting a mathematical model of glycolysis was published by 
Tom Rapoport, Reinhart Heinrich, et al. in 1974.  The goal was to “…test whether their 
linear theory [would] suffice for a description of the steady state” and to determine 
whether a simpler understanding could be derived from glycolysis if the entire chain 
were connected together [21]. 
To test their linearization theory, they constructed a linear system of equations 
through a process of setting the velocities of two reactions in individual equilibrium 
equal to each other, solving for a particular substrate, and then substituting it back into 
another equation.  By repeating this process, they were able to arrive at a single 
equation.  This could be done because they did not consider the reverse reactions in the 
model. For instance, they assumed that the accumulation or removal of lactate would not 
affect the formation of glucose-6-phosphate or fructose-6-phosphate.  By modeling 
glycolysis in erythrocytes, they were able to eliminate many of the subsequent pathways 
that are present in other cells but not present in erythrocytes, the most important being 
the citric acid cycle and oxidative phosphorylation.  They also chose not to include any 
of the pentose phosphate pathways in the experiment, as they felt that at pH 7.2, they 
would contribute only about 10% of the output flux.  The authors considered the 
reactions of hexokinase, phosphofructokinase, and pyruvate kinase to be irreversible, 
due to their high negative ΔG values and all others to be in equilibrium.  The 
concentration levels of glucose were considered constant and saturating.  Lactate was 
always considered to be removed from the cell.  Last, they did include 2,3-
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bisphosphoglycerate bypass in their system as an irreversible reaction and modeled the 
cycling of NAD and NADH. 
The result of their work was the successful creation of a crude model through 
which they obtained values for Glucose—6-Phosphate, Pyruvate, and MgATP that 
roughly approximated the values that are known to exist today.  But the many 
simplifications left much to be expanded upon by future models. 
Rapoport and Heinrich followed up their 1974 paper twice in the next three years 
by adding to their model the synthesis and consumption of ATP [22-24] .  They still 
modeled the reactions as forward-only processes and considered all the reactions 
involving hexokinase, phosphofructokinase, pyruvate kinase, bisphosphoglycerate 
mutase, bisphosphoglycerate phosphatase, and the ATP-consuming processes (labeled 
ATPase in the diagram) to be irreversible. Their model assumes the reactions involving 
aldolase, glyceraldehyde 3-phosphate dehydrogenase, triosephosphate isomerase and 
lactate dehydrogenase to be in equilibrium and those reactions are skipped in the model 
presented in Figure 5.   This work was a step forward in the modeling of glycolysis 
because it explicitly modeled the use and creation of ATP. 
 
 
Figure 5  Rapoport and Heinrich's 1975 model of erythrocyte glycolysis.   
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 In 1981, Ataullakhanov et al. expanded upon Rapoport and Heinrich's work by 
determining ATP is a strong inhibitor to phosphofructokinase and glucose-6-phospahte 
is an inhibitor to hexokinase.  These insights were eluded by exposing erythrocytes to 
levorin, ouahain, and different sodium and potassium ion concentrations.  These helped 
raise and lower the ATP concentrations and other metabolites in the cell without 
disrupting the glycolysis pathway.  The result was they could measure the inhibitory 
effects [25, 26].    
 In 1989, Joshi and Palsson published one of the most comprehensive models 
[26].  The model included glycolysis, the phosphate pentose pathway, the adenosine 
metabolism, the NA/K pump, osmotic pressure, and membrane transport.  While all of 
these components had been performed together by other models, they had not yet been 
all combined together into a single model.   
 Ten years later Mulquiney and Kuchel published an updated model and focused 
on including the 2,3-bisphosglycerate (2,3-BPG) shunt to the model.  The shunt is an 
alternate pathway for glyceraldehyde-3-phosphate to follow to 3-phosphoglycerate and 
2,3-BPG is used to build many secondary metabolites in erythrocytes; thus, its regulation 
was important to deduce.  Previous models did not account for these regulatory 
elements, and papers that did discuss there inclusion did not account for the 
discrepancies between the in vivo and in vitro substrate concentrations related to its 
inclusion [9, 20, 27] .  Four years later, the same authors wrote a book discussing how to 
model metabolism in erythrocytes, called Modeling Metabolism with Mathematica [3].  
This text was very useful in understanding which equations needed to be included in the 
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model and outlined most of the methods necessary to produce the human erythrocyte 
model, even though further material needed to be found to actually produce working 
algorithms.  This was because most of the methods described required the use of 
Mathematica and its library, which are not able to be integrated into Silverlight 
applications.   
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3.  METHODOLOGY 
   
 The following outlines the input formats and major algorithms that were written 
to produce the simulation.  An outline of all the equations generated by the King-Altman 
method is included in the Appendix. 
 
3.1  INPUTTING MODEL INTO INPUT FORMAT 
 This section outlines how to enter the model into the XML data format that is 
read by the software.  
 
Reaction Constituents 
 Reaction Constituents outlines the reaction molecules recognized by the model.  
This list includes names of substrates and enzymes that are present in the model. 
 
Variables 
  
 In Variables, all the model level variables are entered as name-value pairs.  
Common variables are pH and external volume size.  The first is used to specify the 
general pH of the environment, assuming the pH in the environment is buffered.  The 
second is used to specify the volume of the external environment, which in this case 
would be the area around the cell that is able to pass constituents to the erythrocyte. 
 
Mechanism Schematics 
  
 All the enzyme mechanism declarations that can be used to create a rate equation 
for a particular enzyme are included in Mechanism Schematics.  Since a single 
mechanism declaration can be used for multiple enzymes, it is necessary to declare them 
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in a separate input section.  Each mechanism is given a name that can be referenced by 
the enzyme declarations. 
 
Enzymes 
  
 The enzyme declaration defines how an enzyme will be numerically described in 
the modeling environment if a reaction utilizes the enzyme.  Describing an enzyme 
indicates that it is available for use—not that it necessarily will be used for a reaction.  
However, an enzyme has to be used by a reaction for the rate equation to be included in 
the simulation.  Separating the reaction definitions from the enzyme definitions permits 
the same enzyme declaration to be used in more than one reaction or container. 
 The dynamics of an enzyme in this modeling environment can be described in 
two ways, depending upon the information available and the complexity of the enzyme 
mechanism that is being described.  If the enzyme mechanism standard (uni-uni, bi-bi, 
etc.) and the KCat, kM, and kI values are known, then the enzyme can be defined by just 
specifying those values in nested declaration sections. 
 However, if the enzyme is using a mechanism-based method for describing its 
rate equation, then only the mechanism attribute in the enzyme declaration with the 
value set to the name of the mechanism is needed.  Additionally, the enzyme declaration 
requires a mechanism constant mappings component nested within the enzyme 
declaration specifying the values for each of the constants in the mechanism. 
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Binding Sites Declarations 
 
 If a non-mechanism-based description is employed, a list of binding sites needs 
to be entered for each enzyme, primarily to specify where inhibitors and activators bind 
to the enzyme.  With this information, it is possible to determine which substrate and 
inhibition constants need to be bound together when building expressions for 
competitive inhibitors. 
 
Km Declarations 
 
 A list of  kM   values must be supplied for enzymes using a non-mechanism-based 
description.  Also, the primary reactant and product in the enzymatic reaction require 
defined kM  values.  
 
Kcat Declarations 
  
 Enzymes using a non-mechanism-based description need a list of kCat  values.  
The primary reactant and product in the reaction require defined kCat  values, as they are 
used to determine the forward and reverse rate constants for enzymatic reactions. 
 
Ki Declarations 
 
 A list of  kI  values needs to be supplied for enzymes that are using a non-
mechanism-based description.  The primary and all secondary reactants and products in 
the enzymatic reaction need defined kI  values.  These are used to build denominator 
terms as well as inhibitor and activator expressions. 
 
 
 
 37
Inhibition Groups 
  
 For each enzyme that is defined without specifying a mechanism, inhibition and 
activation groups can be defined.  An inhibition group is a collection of inhibitors whose 
concentration can be considered a single concentration.  An activation group acts in the 
same manner as an inhibition group and is implemented the same way.  Often, their 
constants are the only differences between the two. 
 
Inhibitors and Activators 
  
 An inhibitor or activator declaration is used to define the existence of a particular 
inhibitor/activator in an inhibition/activation group.  The name of the inhibitor/activator 
must correspond to a reaction constituent declaration above. 
 
Allosteric Declaration 
  
 In some cases, such as that involving phosphofructokinase, to properly describe 
the enzyme, information about the allosteric structure must be described.  This 
description includes specifying the number of subunits, the inhibitors and activators, the 
standard pH value that was present when the inhibition and activation constants were 
derived, and whether increases in pH inhibit or activate the enzyme.  All the above 
properties are attributes that can be set in the allosteric section, except for the inhibitor 
and activation information specified in the same manner as normal inhibitors and 
activators described earlier. 
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Containers 
  
 The model is first broken down into multiple simulation containers, each 
representing a bound region of space where molecules can interact.  For the purpose of 
this model, there is just one container that needs to be simulated and that is the inside 
contents of the erythrocyte. 
 
Reactions 
  
 The modeling environment supports two types of functions.  The first is the 
ability to programmatically drive the reaction.  In this situation, the user needs to supply 
the name of the class that can be instigated and that will act as a rate equation.  The 
second, which is what most users will use, is the enabling of reactions by specifying an 
enzyme, reactants and products.  If the second is being used, the user must specify the 
name of the enzyme and a list of products and reactants that will result from executing 
the reaction. 
 To aid debugging of the software, each of the reactions in the model can be 
disabled or enabled by setting the enabled attribute of each reaction declaration to true or 
false. 
 
Initial Conditions 
  
 Before the simulation can be run, all of the reaction constituents must be 
assigned initial concentrations for each container.  If a value is not assigned an initial 
concentration, then the value is assumed to be zero at the time the simulation starts, 
which can result in the simulation crashing. 
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Expected Values 
  
 At the end of each container, it is often useful to define a list of expected values 
that should result once the simulation is complete.  This allows the system to compare 
obtained values with expected values and then to provide a percentage difference 
calculation in the results.  This information is useful not only in comparing different 
models but also in debugging a model. 
 
Entered Enzymes 
 The following outlines how the various enzymes were entered into the 
simulation, since it supports multiple methods. 
 Hexokinase was entered into the simulator by specifying its kM,   kI, and   kCat 
constants along with the reactants and products.  It follows a normal bi-normal reaction 
scheme model with four possible inhibitors that can interact with the enzyme, depending 
upon what reaction constituents are present in the container. 
 Glucose phosphate isomerase is just a standard uni-uni reaction and was entered 
by specifying reactant, product, and relevant constants. 
 The enzyme phosphofructokinase was modeled the same way as hexokinase, by 
specifying the reactants and products involved in the reaction and kCat  and  kM  constants. 
In addition, the KT and KR constants describing its allosteric activators and inhibitors 
were provided.  Effects of pH were taken into account by specifying the preferred pH for 
allosteric activation. 
 The aldolase enzyme does not use a standard uni-uni or standard bi-bi random 
reaction, and, thus, the standard modeling software could not support its creation using  
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kM   parameters and substrates alone.  Instead, this enzyme was modeled by outlining its 
mechanism, supplying a list of rate constants for each of the individual steps in the 
mechanism, and solving for the rate equation using the King-Altman method.  
 The interconversion of dihydroxyacetone phosphate to glyceraldehyde 3-
phosphate via triosephosphate isomerase is best inputted using the kM  values of the 
reaction, since the reaction is a standard uni-uni reaction. 
 Glyceraldehyde 3-phosphate dehydrogenase is modeled the same way as aldolase 
enzyme by specifying its mechanism.  This procedure is again due to its mechanism 
being non-standard.   
 Phosphoglycerate kinase follows the standard bi-bi reaction scheme and, thus, 
was entered the same way as hexokinase was entered.  Pyruvate and enolase were 
entered this way as well.   
 Phosphoglycerate mutase follows the standard uni-uni reaction scheme and was 
entered the same way as glucose phosphate. 
 Last, to remove excess pyruvate from the system, it is necessary to include a 
definition for the enzyme lactate dehydrogenase in the reaction scheme.  This enzyme 
was modeled by entering its mechanism and constants, as its mechanism was not a 
standard bi-bi or uni-uni reaction. 
 
Entered Reactions 
  
 A reaction for each of the above enzymes was entered into the reaction list.  In 
addition, to the standard glycolysis reactions, it was necessary to include additional 
reactions used to properly maintain the balances of various energetic compounds in the 
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model.  For instance, to regulate the amount of Mg-Atp and Mg-Adp in the system, 
simple first order kinetics reactions were coded and added to the system as custom rate 
equations.  In addition, custom reactions were created to model the export of lactose and 
pyruvate, consumption of ATP by other extraneous processes in the cell, and the 
consumption of NADH.  The equations of all of these supporting reactions are described 
in [3].  
 
Initial Conditions 
 Table 18 lists the initial conditions that were used in the simulation. 
 
 
 
Table 18 - Assigned initial conditions 
Reaction Constituent Concentration (M) Reaction Constituent Concentration (M)
Glucose 5.00E‐03 Atp 2.10E‐03
Glucose‐6‐Phosphate 4.00E‐05 Adp 3.10E‐04
Fructose‐6‐Phosphate 1.30E‐05 Amp 3.00E‐05
Fructose‐1,6‐Bisphosphate 2.70E‐06 NAD 6.00E‐05
Glyceraldehyde‐3‐Phosphate 5.70E‐06 NADH 1.40E‐07
Dihydroxyacetone Phosphate 1.90E‐05 NADP 1.25E‐07
1,3‐Bisphosphoglycerate 7.00E‐07 NADPH 6.40E‐05
2,3‐Bisphosphoglycerate 2.95E‐03 Hexokinase 2.50E‐08
3‐Phosphoglycerate 6.40E‐05 Glucose Phosphate Isomerase 2.18E‐07
2‐Phosphoglycerate 1.00E‐05 Phosphofructokinase 1.10E‐07
Phosphoenolpyruvate 2.30E‐05 Aldolase 3.70E‐07
Pyruvate 6.00E‐05 Triose Phosphate Isomerase 1.14E‐06
Lactate 1.40E‐03 Glceraldehyde‐3‐Phosphate Dehyd 7.66E‐06
Glucose‐1,6‐Bisphosphate 1.22E‐04 Phosphoglycerate Kinase 2.74E‐06
Glutathione 3.20E‐03 Phosphoglycerate Mutase 4.10E‐07
Mg 3.00E‐03 Enolase 2.20E‐07
MgAtp 0.00E+00 Pyruvate Kinase 8.70E‐08
MgAdp 0.00E+00 Pyruvate (External) 8.50E‐05
MgB23PG 7.61E‐04 Lactate (External) 1.82E‐03
MgB13PG 0.00E+00 Phosphate (External) 1.92E‐03
MgPhosphate 0.00E+00 MgFructose‐1,6‐Bisphosphate 0.00E+00  
 42
3.2  CREATING A DYNAMIC MODEL 
 With the simulation input specified, the simulation environment next parses the 
input file using a supplied XML reader class and then builds an object model.  This 
object model is considered to be dynamic, due to the fact that information can be added 
or removed from the model without causing the model to become invalid. That ability is 
because the simulation does not assume anything about the definition state of the model 
and only acts to hold and collect information that could be useful in defining a particular 
instance of the model.  The same information also can be used to run multiple concurrent 
models, since this is not the model that is used to actually perform the simulation. 
 While the current user interface permits only the text file to be imported and used 
to generate a static model directly from the dynamic model, the next version of the 
program will allow the user to change information in the dynamic model before 
generating a static model.  Thus, while this separation is not a huge factor in this version 
of the software, it will be in future versions. 
 
3.3  CREATING A STATIC MODEL 
 When a simulation is ready to run, a copy of the dynamic model is produced and 
a static model is formed.  This static model represents an unchanging model and is 
necessary for quick execution and for helping to ensure that no information is missing 
before the model is simulated.  Unlike the dynamic model, the static model is a ridged 
model that is read only, and all of the named references are resolved into actual pointers 
to objects in memory.  As these objects are created, they are assigned references to their 
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schematics, and individual instances of the enzymes and constants involved in the 
reactions are assigned variables. 
 
3.4  CREATING A SIMULATORY MODEL 
  
 Once the static model is created, the last step is to collect all of the information 
that is needed to actually create a model that can be simulated.  This includes generating 
all of the rate equations from the static model, gathering a collection of variables that can 
be manipulated during the execution, and creating a set of equation variable mappings. 
 
3.5  USING THE KING-ALTMAN METHOD TO GENERATE EQUATIONS 
 When the user specifies a mechanism to be used instead of a rate equation, the 
simulation environment must solve for the rate equation mathematically before being 
able to construct a working simulation.  Therefore, the user must know all the 
elementary rate constants involved in the mechanism.  
 For an example of what text is being parsed, see Equations 2.12 and 2.13 with 
respect to the aldolase reaction.  A user must enter an overall equation, a list of 
intermediates (if there are any), and a list of the mechanism steps.  The following is an 
example of a valid input that, when parsed, generates the standard Michaelis-Menten 
equation v=kcat*S / (kM+S). 
 
   [reaction] 
    E + A ---> E + P 
   [mechanism] 
    E + A <==> EA {1} 
    EA ---> E + P {2} 
   [end] 
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 For a more complicated example, the hexokinase reaction would be entered in 
the following manner: 
   [reaction] 
    E + A + B <==> E + P + Q 
   [inhibitors] 
    I 
         J 
         K 
         L 
   [mechanism] 
    E + A  <==> EA 
     EA + B <==> EAB 
               E + B <==> EB 
    EB + A <==> EAB 
            EAB <==> EPQ 
            EPQ <==> EP + Q 
           EP <==> E + P 
            EPQ <==> EQ + P 
           EQ <==> E + Q 
    EB + I <==> EIB 
    EB + J <==> EJB 
    EB + K <==> EKB 
    EB + L <==> ELB   
   [end] 
 
The mechanism is a standard Bi-Bi reaction, meaning two inputs and two outputs, with 
four inhibitors that can react with the enzyme complex EB. 
 Once this text has been entered and identified in the XML file, the next step is for 
it to be scanned and tokens identified. 
 
Scanner 
  
 The first thing that must be done to convert a text description of a mechanism to 
a working rate equation is to scan the text and identify tokens, or groupings, of text.  As 
these tokens are identified, they are sent to the parser to determine the meaning of their 
sequence.  For instance, the following line of text would be broken down into eight 
tokens, ignoring white space. 
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A + B <--> AB {1} 
 The above line says the substrates A and B react and form the substrate AB, that 
the reaction is a bidirectional reaction, and it should be assigned the k constants k1 and  
k -1.   It also represents one step for a mechanism that would have N steps, where N is at 
least one.   
 Also for scanning, it was necessary to develop a line reading tool that looked for 
all of the possible input types reading the sequence one character at a time.  These input 
types include the names of the substrates, the plus sign, the directional arrows, the 
constant number assignment in brackets that could exist at the end of each mechanism, 
and line breaks.  When one of these patterns was identified, the scanner generated a 
token and passed it to the parser. 
 
Parser 
  
 The parser’s job is to determine the context of the text tokens.  Recognizing the 
existence of a token does not mean the token is in the correct location or that it has a 
particular meaning in the current context.  For instance, a plus sign has to follow a name 
of a substrate and cannot start a line. 
 As tokens are generated by the scanner, the parser uses them to generate object 
graph in memory representing the inputted text.  This procedure includes determining  
the inputs and outputs of the overall equation, making a list of inhibitors and other 
modifiers, constructing a list of mechanism steps, and producing a set of rate constants 
for each mechanism.  For all this to occur, a single parsing method is defined that takes 
in the current token, the last token, and assesses whether an equal sign has been seen yet 
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on the current line as arguments.  Given no errors, the result is an abstract syntax tree 
that represents the inputted mechanism and that is ready to be converted into a rate 
equation. 
 
Building the Rate Equation 
 With all of the information parsed, the next job is to actually build the rate 
equation.  This is done in a series of nine steps.  The basis of this procedure is 
documented [18, 28], but it leaves many details for the user to work out and clarify.  
This section tries to resolve those issues by outlining an implementation of the 
procedure. 
 The first step in constructing the rate equation is to build a table that will specify 
which constants and substrates are coming into an enzyme complex and toward which 
enzyme complex they are heading next. The size of the table, both length and width, is 
equal to the number of unique enzyme intermediates that exist, including the raw 
enzyme.  The first step in constructing this table is to assign each of the enzyme 
substrates a row number.  Next the actual array that will be used for the table is 
instigated in memory, and every element in the table is assigned its row and column 
number.  This allows for the elements to be added to a list later and also for a later 
algorithm to figure out what table position they were initially assigned. 
 With the table built, it is now possible to go through the list of reaction 
mechanisms and assign each one of them to a slot.  But before this is done, the system 
ensures that each mechanism has a pair of constants associated with it.  It is possible that 
during the parsing that a constant was not assigned if one was not specifically 
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mentioned; and in that case, before this step is over, a constant pair is assigned to the 
mechanism.   
 The next step is for the system to create a list of enzyme complexes that are in 
the system and to separate them from the substrates and intermediates that enter and 
leave the system.  This is managed by first identifying the substrate that is conserved in 
the overall reaction and then identifying all of the substrates that start with the same 
pattern of characters.  If there is no conserved substrate, it assumes that the enzyme 
complexes in the mechanism list start with the capital letter E.  Next, a search is done 
against the reactants and products of each reaction to identify those reactants and 
products in the enzyme complex.  For each set of substrates, the enzyme complex is 
recorded. Then the mechanism is broken up into one or two reaction segments, one 
segment for each direction the mechanism goes.  For each segment, the associated rate 
constants, substrates produced, and direction are assigned.  This is an important step, as 
later this information will be used to determine if substrate cycles exist, which are 
eliminated from the numerical results.  All mechanisms that produce products are 
marked as well.  This procedure is used to determine which ones are candidates for 
producing the numerator expression.  
 The next step is to create an expression for each entry in the previously produced 
table.  The expression is the sum of all of the reaction segment expressions, and each 
reaction segment expression is the product of all of the constants and substrates that 
occur at that particular segment.  The result of this calculation is an adjacency matrix 
which is displayed in the programs output.   
 48
 Next the determinate of this matrix is calculated, and a potential set of numerator 
candidate terms is produced.   To calculate the determinate, one row is skipped at a time; 
then for each remaining row, a set of expressions is produced from each cell in the 
adjacency matrix, with one cell, and thus expression, from each row.  The resulting set is 
multiplied together and this process continues until all possible combinations of 
expressions are created, given no row contributes more than one cell at a time.  After the 
terms are multiplied, they are simplified using the computer algebra system, if possible. 
Not all of the previous resulting expressions are valid numerator and denominator terms. 
To determine which ones are valid, they must be analyzed to determine if any loops are 
present.  If so, they need to be removed. (A loop is defined as two constants from the 
same mechanism appearing in the same term, thus creating a partial net cancellation of 
molecular flux in the mechanism.)  The expressions are checked one at a time by 
isolating the constants and seeing if every constant is discoverable from every other 
constant in the expression through the use of the adjacency matrix.   
 Numerator terms can then be outputted.  Which set of numerator terms is chosen 
to output does not matter, as long as expressions describe only one of the substrates, not 
all of them.  For instance, if it is a bi-bi reaction and two outputs, P and Q, are produced, 
only one set of numerator terms should be produced for either P or Q.  This is because 
the expressions describe the change in flux of the system, and the change in flux in P is 
the same as the change in flux in Q.  
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 The denominator terms can also be outputted at this time, but there is no 
restriction on what terms should be outputted.  Any term that did not have a cycle in it 
gets added to the denominator.   
 Before the final numerator and denominator are produced, like terms are 
collected and grouped together to produce significantly shorter expressions. This step, 
while not necessary, does result in faster simulation speeds. 
 
3.6  DEVELOPMENT OF A COMPUTER ALGEBRA SYSTEM 
 It was necessary to create a small computer algebra system to express all of the 
dynamic expressions that are built by the rate equation builder and to perform necessary 
rearrangements and simplifications to produce results that can be simulated from the 
King-Altman Algorithm.    
The first step in building the computer algebra system was to realize that the 
central abstract concept in the system needed to be the concept of an expression.  An 
expression was recursively defined in this system as a collection of additional 
expressions and a single function that can be applied to the expression list.  Operations 
that are currently supported include addition, subtraction, multiplication, division, and 
the power function.  
 The next step was the development of algorithms to simplify expressions and to 
group constants together.  This procedure is necessary because the King-Altman 
algorithm can produce equations with thousands of terms in them, and most are repeated 
over and over again.  If the equations were evaluated in this expanded format, the 
simulation environment would slow to a crawl and waste large amounts of memory.  To 
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prevent this slowdown from occurring, the equations produced by the King-Altman 
algorithm must be passed to a simplification and grouping algorithm.   
The computer algebra system also supports the ability to print individual 
expressions to the console or to the browser by applying html markup. 
 
3.7  SIMULATING A MODEL  
 A copy of the simulation machinery is created in memory and initialized.  This 
initialization includes specifying error thresholds, the amount of time the simulation 
should be simulated, and the minimum step size that should be used by the differential 
equation numeric solver.   
Building the Equations 
 
 The simulation environment can build equations in three different ways, 
depending upon the complexity of the rate equation: through the specification of kM and 
kCat constants, from a specified mechanism, and from a type declaration.   
 
From Km and Kcat Constants 
  
 The first way of building a rate equation is by building it one term at a time based 
upon the list of reactants, products, kM, kI, and kCat values, and by determining whether 
the rate equation is a standard uni-uni, bi-uni, or bi-bi reaction.  Using the computer 
algebra system, the reaction information and the enzyme information are read and a 
numerator expression and a denominator expression are built for both the forward and 
reverse equations, resulting in a standard rate equation.  
 51
 To calculate the numerator, the reactants or products concentrations are 
multiplied against each other along with the forward or reverse rate constants, and then 
the entire expression is divided by the relevant kM or kI terms for each of the products 
or reactants.  The denominator is the numerator expression plus the individual reactants 
or products divided by the relevant kM or kI value. 
 If the equation has allosteric properties, the denominator of the rate equation is 
modified by multiplying the current denominator by (1 + L), where L is the allosteric 
modification equation defined earlier.  
 If the individual constants are pH specific, expressions for constants are created 
that take the pH into account, and then those expressions are incorporated into the 
equation as if they were constants. 
 If the equation operates across containers, the equation is multiplied by the 
internal volume. 
 
From a Mechanism 
  
 The second way of building a rate equation is to solve for the rate equation using 
the King-Altman algorithm discussed in detail above.  Given a closed reaction 
mechanism and a conserved enzyme, a rate equation can be produced and added to the 
list of equations to be solved numerically.  After the static model is built, but before the 
simulation is run, the simulation environment checks for reactions which have enzymes 
with mechanisms.  If any is found, the King-Altman algorithm is called, and a rate 
equation, along with a series of constants, is returned.  Each of the returned constants is   
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matched up first with the mechanism constant mappings declared in the enzyme 
definition and then assigned a value.   
 
From a Type 
  
 The last way of simulating equations is the universal catch all, which permits 
equations to be written directly in any .NET language, instigated, and then added to the 
equation list.  This process allows any equation form to be added to the system, 
regardless of whether it is a simple rate equation or a complex formula that is pulling 
information from another website.   To use this mechanism, it is necessary to set 
componentType attribute in the reaction declaration to an instantiable type.  If the 
type is not part of the built in simulation software, but is available in the executing 
directory in an external assembly, it can be loaded by specifying the name of the 
assembly in the main configuration file. 
 
Execution of the Adaptive Runge-Kutta Algorithm 
  
 The Runge-Kutta algorithm used for this model is defined in Numerical 
Mathematics and Computing  in an abstract mathematical form [29].  It specifies how to 
solve a single equation using the Runge-Kutta algorithm with a fixed step size, a single 
equation with a variable step size with built in error detection, and a series of equations 
with a fixed step size.  But it does not specify how to use the adaptive algorithm for 
multiple equations or how to adapt it for the use of a Computer Algebra System. Instead, 
it leaves the reader to combine the two algorithms.  Since one of the themes of this thesis 
is saving scientists time and learning how to automate tasks, this section will explain 
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how adaptive step size Runge-Kutta algorithm was merged with the variable and 
expressions emanating from the computer algebra system. 
 A total of two Runge-Kutta-based algorithms were developed for this project.  
The first was a fixed step size algorithm.  This was used in the initial testing phases of 
the project, but as the number of equations passed one and some volatile equations were 
produced, it was necessary to develop an algorithm that had an adaptive step size.  Thus, 
the second algorithm was based upon the Runge-Kutta 5th order implementation with 
error checking.   This one always permits the step size to vary during the course of the 
simulation, as long as the error bounds are not violated.  If the error for any particular 
calculation moves above the higher bound, the step size will decrease; and if no upper 
bound is exceeded, but a lower bound is exceeded, the step size will grow larger.  The 
rest of the description pertains to this latter algorithm. 
 The algorithm is divided into two phases, the first being the repetitive phase and 
the second being the calculation phase.  When the Runge-Kutta algorithm is called, all of 
the following are passed in to be modified:  a series of variables, a series of equations, a 
set of variable to equation mappings, the index of the variable used to specify the time (if 
there is one) an estimated starting step size, the maximum allowed error per calculation, 
the minimum error per calculation, and a data emitter used to output statistics.  The 
algorithm starts by initializing variables and then segues into the time loop that will 
determine when the algorithm ends, which occurs when the simulation time equals the 
target time.  The next step is to evaluate each of the passed equations with the current 
step size and variable values.  This is done by calling the second evaluation function, 
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which will be described shortly.  The results of the evaluation call are a change amount 
and an error.  The next line checks to see if any of the error boundaries were violated 
during the process.  An error boundary can be violated if the error returned is not a 
number and if it exceeds the error maximum or the error minimum.  In the first two 
cases, the loop is aborted and the step size is reduced.  The reason why the 'not a number' 
result is treated as a maximum error violation is that if the step size is too big, it can 
cause any term with a power quickly hit infinity during the five-step evaluation phase.  
On the other hand, if no aborts occurred, and a minimum error violation occurred, the 
step size will increase in subsequent steps to speed the execution along.  Last, if no 
errors occurred, or if only minimum error violations occurred, after all the functions are 
evaluated, the changes in each function are mapped to the current variables based upon 
the stoichiometry of the system.   This stoichiometry information comes in the form of 
the variable mappings that were passed as an argument to the function.   
 The calculation phase of the Runge-Kutta algorithm is relatively straight forward 
and follows what is given in the book Numerical Mathematics and Computing [29].  The 
calculation phase takes in a list of variables and in the equation that is being simulated.  
All six steps of the Runge-Kutta algorithm are calculated as outlined in the literature, 
and the error is calculated by subtracting the fourth order answer from the fifth order. 
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Outputting Results 
 The system outputs a series of standard HTML reports to a browser after each 
run of the program.  These include final concentrations for each substrate, and the step-
by-step production of rate equations which were inputted using rate equations.   
  These reports are fairly easy to generate, with the result being a generated 
HTML file, but to display the report inside the Silverlight environment is a problem.  
This is because Silverlight does not support the rendering of HTML within a Silverlight 
control; instead it must send back to the browser.  The Silverlight environment does 
support the ability of the program to send information to the browser through a 
JavaScript bridge.  Using this bridge, it is possible for the C# code executing on the 
client to send a segment of html to the browser.   
 This works out rather well, given the report never needs to be printed.  But if the 
data does need to be printed, then the presence of any Silverlight UI on the screen 
control can cause gaps in the report to appear, even if the report is in front of the 
Silverlight control on the z-axis; therefore, even though the UI should be hidden, it still 
remains visible when printed.  This printing problem can be resolved and the user can 
gain a better user interface experience by sending the results of a simulation to another 
tab.  Allowing this resolution required the development of an inter-window 
communication protocol, which allows for very large amounts of html to be sent 
between tabs.   
 Using the third version of Silverlight, it is possible to send up to 10,000 
characters of text between two instances of Silverlight at a time.  To enable reports to 
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show up, the system is set up so that when it first starts, it checks to see if another 
instance of the program is running.  If so, it boots up as a slave to the primary software 
application; otherwise it becomes the primary application.  If it does boot up as a slave 
system, it checks to see if the current system has any tasks that need to be performed, 
including the display of a report.  This communication is accomplished by the 
development of an inter-Silverlight communication protocol.  A communication protocol 
was required so that multiple tabs can communicate to the primary window, the primary 
window would know where the messages were coming from, and responses could be 
sent to the correct window.  In addition, because only 10,000 characters of text could be 
sent at a time and some reports are easily over 20,000 characters in length when HTML 
markup is included in the count, a report has to be sent to another tab in parts and then 
reassembled.  To facilitate larger reports, a multi-part messaging protocol was 
developed.  If the slave system does receive a multi-part message instructing it to display 
just a report, the slave system closes its Silverlight user interface and only displays the 
HTML on screen. 
 
Assumptions 
 This model uses the same set of assumptions that was by Mulquiney and Kuchel 
in their 2003 book.  This allows for the simulation results from the new simulation 
technology to be comparable with their past model.  Of these assumptions, there are few 
worth repeating here.   
 The glucose concentration was kept constant at 0.005M.  This can be done 
because glucose freely diffuses through the membrane and its concentration in the blood 
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stream is buffered.  It is also assumed that the levels of pyruvate, lactate, and inorganic 
phosphate are buffered in the blood stream and any output from the cell to the blood 
stream did not change these levels.  The pH of the system was held to 7.2.   Substrates 
that were important in the regulation of the system but which could not be produced by 
the system of equations as a product in this model were set to their expected values.  
These included glucose 1-6-bisphosphate, glutathione, and 2,3-bisphosphoglycerate.  
None of the reactions involving the pentose phosphate pathway, the 2,3-
bisphosphoglycerate, haemoglobin-metabolite binding, were implemented.  Two 
magnesium-metabolite binding reactions were implemented to get the hexokinase 
reaction working, along with the associated assumption that MgATP is broken down by 
other secondary processes.  These secondary processes were not individually modeled in 
Mulquiney and Kuchel, and an as such were grouped into as single equation in this 
model as well.  The conversion of MgADP to MgATP and AMP via adenylate kinase 
was added to produce AMP that could be an activator for PFK.  Without these processes, 
the ATP levels in the model can become unstable [25].   
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4.  RESULTS AND DISCUSSION 
 
4. 1  SIMULATION RESULTS 
 
 The model was simulated for a total of twenty minutes using the previously 
stated Runge-Kutta algorithm, and no individual calculation was allowed to have an 
error greater than 1E-9.  During this time, the average fluxes per second for all of the 
substrates converged toward zero; thus, the system was able to enter a quasi-steady state. 
Table 19 lists the final steady state concentrations that were not held constant in the 
simulation.   
 
Table 19  Final steady state concentrations of all substrates not held constant 
 
Fructose‐6‐Phosphate 1.40E‐05 1.21E‐05 15.09%
Fructose‐1,6‐Bisphosphate 8.36E‐07 2.23E‐06 62.46%
Glyceraldehyde‐3‐Phosphate 7.49E‐07 5.14E‐06 85.44%
Dihydroxyacetone Phosphate 3.18E‐06 2.14E‐05 85.10%
1,3‐Bisphosphoglycerate 1.15E‐06 3.57E‐07 222.27%
3‐Phosphoglycerate 1.19E‐04 7.09E‐05 68.28%
2‐Phosphoglycerate 1.99E‐05 1.19E‐05 68.29%
Phosphoenolpyruvate 3.77E‐05 1.98E‐05 90.07%
Pyruvate 5.68E‐05 5.86E‐05 3.08%
Lactate 2.10E‐03 1.41E‐03 49.54%
Mg 7.26E‐04 3.83E‐04 89.36%
MgAtp 2.20E‐03 1.53E‐03 44.34%
MgAdp 7.20E‐05 9.56E‐05 24.65%
Atp 1.17E‐04 1.53E‐04 23.78%
Adp 4.31E‐05 1.08E‐04 60.21%  
 
 There are discrepancies between the results presented here and the results 
published by Kuchel and Mulquiney, but the concentrations are close, and the 
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discrepancies are understandable.  Kuchel and Mulquiney implemented the entire 
erythrocyte metabolism, whereas this model implements only glycolysis.  Therefore, 
exact alignment of the concentrations was not expected.  The largest value difference 
occurs with 1-3-bisphosphoglyeracate and can be explained by the fact that the pathway 
is supposed to split in the full model at 1-3-bisphosphoglyeracate to produce 2-3-
bisphosphoglyeracate .  If the 2-3-bisphosphoglyeracate shunt had been implemented, 
over half of the 1-3-bisphosphoglyeracate concentration would have been converted into 
2-3-bisphosphoglyeracate and other secondary downstream derivatives, based upon the 
equations and steady state levels presented in Kuchel and Mulquiney model.   
 The higher than expected amount of 2-3-bisphosphoglyeracate explains why the 
immediate upstream substrate concentrations of fructose-1,6-bisphosphate, 
glyceraldehyde-3-phosphate, and dihydroxyacetone phosphate are lower, as they are 
experiencing a net negative feedback.  Continuing this reasoning, glucose-6-phosphate 
and fructose-6-phosphate are higher because they are experiencing a net positive 
feedback from the high levels of fructose-1,6-bisphosphate.  Additionally, since glucose-
6-phosphate and fructose-6-phosphate are supposed to feed into the pentose phosphate 
pathway (PPP), which is expected to consume ~10% of the arriving glucose   [21], it 
makes sense that these substrates are off by approximately the same amount.  Last, the 
higher upstream levels of 1,3-bisphosphoglycerate will cause the higher levels of 3-
phosphoglycerate, 2-phosphoglycerate, and phosphoenolpyruvate downstream.  The 
levels of MgATP and other energy carriers are off also, but these differences were 
anticipated because a portion of these substrates are expected to be consumed in other 
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pathways if the full model was implemented.  Because MgATP is a product of glycolysis 
and the upstream products are higher, the increased levels of MgATP are expected as 
well.  The high level of NADH is also warranted, given the high level of 1,3-
Bisphosphoglycerate; both NADH and 1,3-bisphosphoglycerate are products of 
glyceraldehyde phosphate dehydrogenase.  The remainder of the energy metabolites are 
consumed in the production of MgATP and NADH; thus, their lower levels are 
expected, given the higher levels of MgATP and NADH in the model. 
 The overall substrate flux of the model appears to be correct since the error 
associated with pyruvate concentration is only 3%, and because pyruvate is one of  the 
three substrate exit points in the system.  The other two are phosphate and lactate.  
Phosphate levels are slightly elevated, but so is the amount of MgATP.   The lactate 
concentrations are higher, at 49.54%, but higher concentration levels of this final 
substrate in the pathway are appropriate, given the higher substrate concentration levels 
upstream and also given that the speed of lactate export is about ten times less than the 
speed of pyruvate at pH 7.2.   Thus, between pyruvate and lactate, it is expected that 
lactate levels will build up first.  
 To determine whether the system was evolving into a quasi-steady state, the 
simulation was allowed to run for 14 hours, and average net flux of each substrate was 
gathered over the course of the simulation.  These averages are depicted graphically in 
an included appendix and visibly demonstrate that the fluxes of the substrates are 
converging toward zero over time.  The convergence was anticipated, as the equations 
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used in this system are the same ones used in Kuchel and Mulquiney's model, and those 
equations converged as well.  
4.2  PERFORMANCE 
 
 The performance of the simulation is currently much slower than other biological 
pathway simulators.  It is currently taking 14 hours to simulate 20 minutes.  This 
performance level was expected due to the un-optimized object-oriented nature of the 
system and due to the slowdowns associated with executing code within the browser 
using the Silverlight dynamic runtime. During early performance tests, it was found that 
code executing within the browser ran about ten times slower than what would be 
expected if the same code were run as a console application.  Thus, one of the first 
improvements planned for later development is a reduction in the number of objects 
being referenced in calculations as well as the number of steps in the simulation without 
drastically increasing the amount of error in results.   
 
4.3  NEXT STEPS 
  
 The next step in the development of this modeling engine will be the addition of  
a more extensive user interface and peer-to-peer functionality.  The current user interface 
is rather minimal, as most of the input is done by entering information into a XML text 
document.  This procedure suffices for the first version, since the objectives were 
focused around the development of the simulation engine and not ease of input.  These 
user interface additions will also allow the user to manage inputs arriving from 
additional sources through the application.   
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 After modification of the user interface, the next goal is the addition of extensive 
peer-to-peer collaboration functionality to the simulation environment.  That upgrade 
should be a minor undertaking because the system was built using Silverlight and runs 
within the browser. Many of the current Web 2.0 technologies are designed to interface 
with the browser and web applications.    
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5.  SUMMARY AND CONCLUSIONS 
 
 The purpose of this study was to build a biological pathway simulator in 
Silverlight and to test it by using it to model glycolysis in erythrocytes.  The long term 
goal of this project is to enable and encourage the collaborative development of meta-
simulations.  It is hoped that in laying the foundation for the development of 
collaborative features in this project that the long term objectives of the project can be 
accomplished by future versions of the software.  This study required the development 
of the simulator as well as several supporting technologies, including a small computer 
algebra system and the modification of a King-Altman algorithm for use in Silverlight.   
The simulator simulated a model of glycolysis converged to a quasi-steady state and 
whose final steady state concentrations were relatively close to those produced  by other 
more complex erythrocyte metabolism models. Last, while the current system is slower 
than that of current modeling engines, it is anticipated that through further development 
and optimization, it can become an important modeling tool for the community by being 
able to produce meta-models through real-time collaboration.     
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APPENDIX A 
 
 The following is a table and a list of corresponding graphs showing the average 
flux of each of the substrates whose concentrations were variable converging toward 
zero as time increased.   
Elapsed Seconds 1 5 10 15 30 60 120 300 600 1200
Elapsed Minutes 0.02 0.08 0.17 0.25 0.50 1.00 2.00 5.00 10.00 20.00
Glucose‐6‐Phosphate ‐2.9E‐07 ‐3.4E‐07 ‐3.1E‐07 ‐2.8E‐07 ‐2.1E‐07 ‐1.3E‐07 ‐6.0E‐08 ‐1.5E‐08 ‐1.8E‐09 2.7E‐09
Fructose‐6‐Phosphate ‐2.8E‐07 ‐1.4E‐07 ‐1.2E‐07 ‐1.0E‐07 ‐7.2E‐08 ‐4.3E‐08 ‐2.0E‐08 ‐5.0E‐09 ‐7.3E‐10 8.1E‐10
Fuctose‐1,6‐Bisphosphate ‐1.4E‐07 ‐2.6E‐07 ‐1.5E‐07 ‐1.1E‐07 ‐5.8E‐08 ‐3.1E‐08 ‐1.6E‐08 ‐6.4E‐09 ‐3.2E‐09 ‐1.6E‐09
Glyceraldehyde‐3‐Phosphate ‐3.5E‐06 ‐1.0E‐06 ‐5.2E‐07 ‐3.5E‐07 ‐1.8E‐07 ‐8.9E‐08 ‐4.5E‐08 ‐1.8E‐08 ‐8.7E‐09 ‐4.1E‐09
Dihydroxyacetone Phosphate ‐9.0E‐06 ‐3.3E‐06 ‐1.7E‐06 ‐1.1E‐06 ‐5.8E‐07 ‐2.9E‐07 ‐1.5E‐07 ‐5.8E‐08 ‐2.8E‐08 ‐1.3E‐08
1,3‐Bisphosphoglycerate ‐4.1E‐07 ‐7.4E‐08 ‐3.5E‐08 ‐2.3E‐08 ‐1.1E‐08 ‐5.3E‐09 ‐2.6E‐09 ‐8.2E‐08 ‐1.3E‐10 3.8E‐10
3‐Phsphoglycerate 1.2E‐05 4.9E‐06 2.7E‐06 1.9E‐06 9.9E‐07 4.6E‐07 1.9E‐07 7.3E‐08 5.1E‐08 4.6E‐08
2‐Phosphoglycerate 2.5E‐06 9.4E‐07 5.2E‐07 3.6E‐07 1.9E‐07 8.7E‐08 3.6E‐08 1.4E‐08 9.7E‐09 8.3E‐09
Phosphoenolpyruvate ‐1.1E‐06 ‐4.6E‐07 ‐2.2E‐07 ‐1.3E‐07 ‐3.8E‐08 ‐1.4E‐08 ‐1.1E‐08 ‐8.6E‐10 6.4E‐09 1.2E‐08
Pyruvate ‐1.3E‐05 ‐4.7E‐06 ‐2.3E‐06 ‐1.4E‐06 ‐4.6E‐07 ‐1.8E‐07 ‐6.3E‐08 ‐6.9E‐09 ‐4.5E‐09 ‐2.7E‐09
Lactate 1.7E‐05 9.1E‐06 6.7E‐06 5.8E‐06 4.6E‐06 3.6E‐06 2.7E‐06 1.9E‐06 1.1E‐06 5.8E‐07
Mg ‐2.2E‐03 ‐4.4E‐04 ‐2.2E‐04 ‐1.5E‐04 ‐7.4E‐05 ‐3.7E‐05 ‐1.9E‐05 ‐7.5E‐06 ‐3.8E‐06 ‐1.9E‐06
MgAtp 2.0E‐03 4.1E‐04 2.0E‐04 1.4E‐04 6.8E‐05 3.4E‐05 1.7E‐05 7.0E‐06 3.6E‐06 1.8E‐06
MgAdp 1.8E‐04 3.5E‐05 1.7E‐05 1.1E‐05 5.5E‐06 2.6E‐06 1.2E‐06 4.2E‐07 1.7E‐07 6.0E‐08
Atp ‐2.0E‐03 ‐4.0E‐04 ‐2.0E‐04 ‐1.3E‐04 ‐6.7E‐05 ‐3.3E‐05 ‐1.7E‐05 ‐6.7E‐06 ‐3.3E‐06 ‐1.7E‐06
Adp ‐2.1E‐04 ‐4.3E‐05 ‐2.2E‐05 ‐1.4E‐05 ‐7.3E‐06 ‐2.5E‐08 ‐1.9E‐06 ‐7.9E‐07 ‐4.2E‐07 ‐2.2E‐07
Amp 8.4E‐06 1.1E‐06 4.3E‐07 2.3E‐07 4.9E‐08 ‐2.5E‐08 ‐4.4E‐08 ‐3.7E‐08 ‐2.9E‐08 ‐2.0E‐08
NAD ‐3.6E‐07 ‐6.5E‐08 ‐3.4E‐08 ‐2.4E‐08 ‐1.3E‐08 ‐9.5E‐09 ‐7.7E‐09 ‐5.9E‐09 ‐5.8E‐09 ‐5.7E‐09
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